Comparison between ROX Hi-Tech IPO and Sunrest Lifescience IPO.
ROX Hi-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sunrest Lifescience IPO is a SME Fixed Price proposed to list at NSE SME.
| ROX Hi-Tech IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Swaraj shares & securities Pvt.Ltd. | Mark Corporate Advisors Pvt.Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Share India Securities Ltd. | Svcm Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ROX Hi-Tech IPO is up to ₹47.45 Cr whereas the issue size of the Sunrest Lifescience IPO is up to ₹10.30 Cr. The final issue price of ROX Hi-Tech IPO is ₹83.00 per share and of Sunrest Lifescience IPO is ₹84.00 per share.
| ROX Hi-Tech IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹83.00 per share | |
| Issue Price (Final) | ₹83.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 51,69,600 shares | 12,25,600 shares |
| Fresh Issue Size (Amount) | up to ₹42.91 Cr | up to ₹10.30 Cr |
| OFS Issue Size | 5,47,200 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹4.54 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,16,800 shares | 12,25,600 shares |
| Issue Size Total (Amount) | up to ₹47.45 Cr | up to ₹10.30 Cr |
ROX Hi-Tech IPO opens on Nov 07, 2023, while Sunrest Lifescience IPO opens on Nov 07, 2023. The closing date of ROX Hi-Tech IPO and Sunrest Lifescience IPO is Nov 09, 2023, and Nov 09, 2023, respectively.
| ROX Hi-Tech IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2023 | |
| Issue Open | Nov 07, 2023 | Nov 07, 2023 |
| Issue Close | Nov 09, 2023 | Nov 09, 2023 |
| Basis Of Allotment (Tentative) | Nov 15, 2023 | Nov 15, 2023 |
| Initiation of Refunds (Tentative) | Nov 16, 2023 | Nov 16, 2023 |
| Credit of Share (Tentative) | Nov 16, 2023 | Nov 17, 2023 |
| Listing date (Tentative) | Nov 16, 2023 | Nov 20, 2023 |
| Anchor Lockin End date 1 | Dec 15, 2023 | |
| Anchor Lockin End date 2 | Feb 13, 2024 |
ROX Hi-Tech IPO P/E ratio is 9.11, as compared to Sunrest Lifescience IPO P/E ratio of 12.33.
| ROX Hi-Tech IPO | Sunrest Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | ROX Hi-Tech Limited Financial Information (Restated)ROX Hi-Tech Limited's revenue increased by 30.12% and profit after tax (PAT) rose by 913.13% between the financial year ending with March 31, 2023 and March 31, 2022.
| Sunrest Lifescience Limited Financial Information (Restated)Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.29 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.11 | 12.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹189.52 Cr. | ₹36.05 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 63.48% | 53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 50.17% | 98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.94 | 0.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.11 | ₹6.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 63.48% | 65.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ROX Hi-Tech IPO Retail Individual Investors (RII) are offered 21,93,600 shares while in Sunrest Lifescience IPO retail investors are offered 21,93,600 shares. Qualified Institutional Buyers (QIB) are offered 10,51,200 shares in ROX Hi-Tech IPO and in Sunrest Lifescience IPO.
| ROX Hi-Tech IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Investor Reserveration | 15,76,000 shares | |
| Market Maker Reserveration | 8,48,000 shares | 65,600 shares |
| QIB | 10,51,200 shares | |
| NII | 8,96,000 shares | 6,12,800 shares |
| RII | 21,93,600 shares | 6,12,800 shares |
| Employee | ||
| Others | ||
| Total | 57,16,800 shares | 12,25,600 shares |
ROX Hi-Tech IPO subscribed 214.44x in total, whereas Sunrest Lifescience IPO subscribed 48.54x.
| ROX Hi-Tech IPO | Sunrest Lifescience IPO | |
|---|---|---|
| QIB (times) | 106.25x | |
| NII (times) | 366.86x | 29.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 204.02x | 65.74x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 214.44x | 48.54x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
